Zoetis Inc. (ZTS) News
Track canonical SquawkNews coverage tagged to ZTS, Zoetis Inc.. This hub brings together deduplicated headlines about united states, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 33 indexed stories across 18 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
ZTS - Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial Results
ZTS - Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial Results
EARNINGS | Sep 24, 2026, 11:40 AM UTC
L
Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, November 5, 2026. Chief Executive Officer Kristin Peck and Executive Vice President, Chief Financial Officer and Chief Operati
EARNINGS | Sep 24, 2026, 11:30 AM UTC
L
ZTS: Innovation and targeted pricing drive resilience amid pet care headwinds and strong livestock growth
Leadership emphasized value creation through innovation and targeted pricing amid a declining pet care market and rising competition. Strong livestock growth and a robust product pipeline, including CKD and oncology, sup
NEWS | Sep 14, 2026, 07:56 PM UTC
L
ZTS: Innovation pipeline and targeted pricing drive resilience amid pet care headwinds and competition
Leadership emphasized value creation through innovation and dynamic pricing strategies amid a cyclical downturn in pet care and heightened competition. Livestock and diagnostics are outperforming, while new product launc
NEWS | Sep 14, 2026, 06:56 PM UTC
L
ZTS - Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
ZTS - Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
EQUITY | Sep 02, 2026, 11:37 AM UTC
L
Zoetis to hold fireside chat at Morgan Stanley healthcare conference
Zoetis says CEO Kristin Peck and CFO Jay Saccaro will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026 at 1:50 p.m.
EQUITY | Sep 02, 2026, 11:30 AM UTC
L
Michael Burry Bought Beaten-Down Stocks And Shorted AI Favorites — Here’s How His August Bets Fared
Michael Burry Bought Beaten-Down Stocks And Shorted AI Favorites — Here’s How His August Bets Fared
EQUITY | Aug 31, 2026, 04:30 AM UTC
L
BNP Paribas Maintains Outperform on Zoetis, Lowers Price Target to $110
BNP Paribas analyst Navann Ty maintains Zoetis (NYSE: ZTS ) with a Outperform and lowers the price target from $146 to $110.
EQUITY | Aug 11, 2026, 05:57 PM UTC
H
5 Stock Picks Last Week From Wall Street's Most Accurate Analysts
U.S. stocks settled higher on Friday, with the Nasdaq Composite gaining more than 300 points and S&P 500 surging to record close during the session. Major indices also recorded gains for the second straight week, with th
EARNINGS | Aug 10, 2026, 09:33 AM UTC
H
Zoetis Sees Softer Pet Health Demand, But Adapting Commercial Strategy to Navigate Headwinds
Zoetis Inc. (NYSE: ZTS ) reported second-quarter adjusted earnings of $1.87 per share, beating the consensus of $1.86. The animal health company reported sales of $2.468 billion, missing the consensus of $2.502 billion.
EARNINGS | Aug 06, 2026, 06:10 PM UTC
H
Zoetis Q2 Revenue $2.468B Misses Estimates
Zoetis reports Q2 revenue of $2.468B
EARNINGS | Aug 06, 2026, 11:46 AM UTC
M
Zoetis Appoints Jay Saccaro as CFO and COO
Zoetis names new CFO and COO
EQUITY | Aug 06, 2026, 11:05 AM UTC
H
ZTS - Zoetis Announces Second Quarter 2026 Results
ZTS - Zoetis Announces Second Quarter 2026 Results
EARNINGS | Aug 06, 2026, 11:05 AM UTC
M
ZTS Names Jay Saccaro CFO, COO
ZTS appoints new CFO and COO
EQUITY | Aug 06, 2026, 11:04 AM UTC
H
Zoetis Lowers FY2026 Adj EPS Guidance from $6.85-$7.00 to $6.15-$6.25 vs $6.88 Est; Lowers FY2026 Sales Guidance from $9.680B-$9.960B to $9.
Zoetis (NYSE: ZTS ) lowers FY2026 Adj EPS guidance from $6.85-$7.00 to $6.15-$6.25 vs $6.88 analyst estimate. Lowers FY2026 sales outlook from $9.680 billion-$9.960 billion to $9.120 billion-$9.320 billion vs $9.726 bill
EARNINGS | Aug 06, 2026, 11:01 AM UTC
H
Michael Burry Expands Bets Against Nvidia, Micron— and Is Now Buying Lululemon and DraftKings
‘The Big Short’ investor Michael Burry has expanded his bearish bets against chipmaker Nvidia Corp. (NASDAQ: NVDA ) while piling into long stakes in Lululemon Athletica Inc. (NASDAQ: LULU ) and DraftKings Inc. (NASDAQ: D
EARNINGS | Jul 31, 2026, 01:19 PM UTC
H
Burry Increases Shorts in MU, NVDA, SOXX
Burry increases shorts in tech stocks
EQUITY | Jul 30, 2026, 08:29 PM UTC
H
ZTS Sees Buying
ZTS experiences buying activity
EQUITY | Jul 30, 2026, 07:54 PM UTC
L
BAH CNI FIX GSHD MRSH PSX RJF RNR SXT THC WRB AAL CHTR HAL HCA IDXX MCD MSFT MTDR ZTS PT changes @ UBS
BAH CNI FIX GSHD MRSH PSX RJF RNR SXT THC WRB AAL CHTR HAL HCA IDXX MCD MSFT MTDR ZTS PT changes @ UBS
EQUITY | Jul 27, 2026, 12:50 PM UTC
L
ZTS Zoetis launches lenivia® (izenivetmab injection) in Canada and the European union
ZTS Zoetis launches lenivia® (izenivetmab injection) in Canada and the European union
EQUITY | Jul 15, 2026, 12:33 PM UTC
L
ZTS Zoetis announces agreement to acquire vitalrads, accelerating diagnostic capabilities Zoetis - financial terms of vitalrads acquisition
ZTS Zoetis announces agreement to acquire vitalrads, accelerating diagnostic capabilities Zoetis - financial terms of vitalrads acquisition not disclosed
MNA | Jul 14, 2026, 01:00 PM UTC
H
Zoetis put volume heavy and directionally bearish
Bearish flow noted in Zoetis with 3,163 puts trading, or 1.6x expected. Most active are Sep-26 65 puts and Sep-26 70 puts, with total volume in those strikes near 2,200 contracts. The Put/Call Ratio is 4.08, while ATM IV
EQUITY | Jul 06, 2026, 04:36 PM UTC
L
Zoetis price target lowered to $95 from $140 at HSBC
HSBC lowered the firm's price target on Zoetis to $95 from $140 and keeps a Buy rating on the shares. In a sector note on Healthcare, HSBC adjusted target prices on the prospects of the sector's relative outperformance p
EQUITY | Jul 06, 2026, 02:27 PM UTC
L
ZTS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zoetis Inc. Shareholders with Losses Have Opportunity to Lead Class
NEW YORK CITY, NY / / July 6, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-ri
EQUITY | Jul 06, 2026, 11:01 AM UTC
L
Zoetis Deadline: ZTS Investors with Losses in Excess of $100K Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit
Zoetis Deadline: ZTS Investors with Losses in Excess of
EQUITY | Jul 05, 2026, 11:44 PM UTC
L
ZTS IMPORTANT DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before
New York, New York--(. - July 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and
EQUITY | Jul 03, 2026, 05:38 PM UTC
L
Investors Urged to Contact Levi & Korsinsky for Information Before July 27, 2026 - Zoetis Inc. (ZTS)
NEW YORK, NY / / July 3, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has b
EQUITY | Jul 03, 2026, 03:50 PM UTC
L
Zoetis Inc. (ZTS) Investors: July 27, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Did you buy ZTS securities between January 14, 2025, and May 6, 20
EQUITY | Jul 03, 2026, 03:30 PM UTC
L
Pomerantz LLP Issues Reminder to Investors in Zoetis Inc. of Class Action Lawsuit – ZTS
NEW YORK CITY, NY / / July 3, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against
EQUITY | Jul 03, 2026, 11:00 AM UTC
L
Securities Lawsuit Alert: Zoetis Inc. (ZTS) Investors – Contact Levi & Korsinsky Before July 27, 2026
NEW YORK, NY / / July 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has b
EQUITY | Jul 03, 2026, 01:30 AM UTC
L
Barclays Maintains Equal-Weight on Zoetis, Lowers Price Target to $85
Barclays analyst Glen Santangelo maintains Zoetis (NYSE: ZTS ) with a Equal-Weight and lowers the price target from $136 to $85.
EQUITY | Jul 01, 2026, 11:14 AM UTC
L
TD Cowen Maintains Buy on Zoetis, Lowers Price Target to $104
TD Cowen analyst Steve Scala maintains Zoetis (NYSE: ZTS ) with a Buy and lowers the price target from $150 to $104.
EQUITY | Jun 30, 2026, 01:41 PM UTC
L
USDA: New Screwworm Case
US Department of Agriculture reports new case of screwworm in a Texas goat, bringing total domestic detections to 16 cases
EQUITY | Jun 23, 2026, 04:17 PM UTC